On June 26, 2024, Meihua International Medical Technologies Co., Ltd. announced a share repurchase plan authorizing the purchase of up to $3 million of its ordinary shares. Additionally, an amended insider trading policy was adopted to enhance corporate governance, effective July 1, 2024.